ACTU · Actuate Therapeutics, Inc.
$1.27
+0.04 (+3.25%)
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$30.50M
Shares
24.01M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-11-28 | — | $100,000,000 | $100,000,000 as of 2025-12-31 | — | 10-K , filed 2026-03-26 |
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
52 filings
52 filers
Visit website
Investor relations